Bacteriophage Market Size, Share, Trends & Forecast
The Bacteriophage Market is gaining attention as healthcare and biotechnology companies explore bacteriophages as targeted alternatives for addressing bacterial infections. The market was valued at USD 0.0548 billion in 2024 and is projected to reach USD 0.0889 billion by 2035, expanding at a CAGR of 4.5% during 2025–2035.
Therapeutic applications currently represent the largest application segment, supported by increasing concern about antibiotic-resistant bacteria and continued research into phage-based treatments. Agricultural applications are also emerging as an important growth area, where bacteriophages can be explored for biological crop protection and reducing dependence on conventional chemical solutions.
Lytic bacteriophages account for the largest type segment because of their ability to destroy targeted bacterial cells. Engineered bacteriophages are attracting increasing research interest as genetic engineering and synthetic biology enable researchers to develop phages with more specific characteristics and potentially broader therapeutic applications.
North America holds the largest regional share, supported by biotechnology investment, research activity, and growing interest in alternatives to conventional antibiotics. Europe is another established market, while Asia-Pacific is developing rapidly as healthcare spending, biotechnology capabilities, and bacteriophage research expand across countries such as China and India.
The future of the Bacteriophage Market will depend on advances in phage engineering, production, delivery technologies, and regulatory pathways. Personalized phage cocktails, improved manufacturing processes, and applications in food safety and agriculture could broaden commercial opportunities as research continues to translate bacteriophage science into practical products.